A jury has awarded a $134.5 million judgment against the pharmaceutical maker Wyeth in a hormone replacement therapy lawsuit filed by three Nevada women who contended that the company's hormone-replacement drugs had caused their breast cancer.
Pharmaceutical giant Wyeth, ordered by a Washoe County jury to pay millions to three Northern Nevada women who claimed the company's hormone replacement drugs caused their breast cancer.
U.S. regulators received more than twice as many reports of deadly or debilitating side effects from drug treatment in 2005 as they did seven years before, a study found.
The women have shared the trauma of facing a cancer that threatened their lives. But they have another factor in common: years spent taking hormone replacement therapy drugs to counter the effects of menopause.
